Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

OPNT - Opiant Pharmaceuticals Inc

Close
20.65
-0.120   -0.581%

Share volume: 0
Last Updated: Wed 01 Mar 2023 10:00:01 PM CET
Medicinal and Botanical Manufacturing : 1.15%

PREVIOUS CLOSE
CHG
CHG%
$20.77
-0.12
-0.58%
This ticker is disabled and data are no longer maintained and up to date.
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
39%
Profitability 53%
Dept financing 33%
Liquidity 46%
Performance 25%
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
-0.29%
1 Month
1.11%
3 Months
4.18%
6 Months
76.39%
1 Year
-22.66%
2 Year
60.55%
Key data
Stock price
$20.65
P/E Ratio 
0.00
DAY RANGE
N/A - N/A
EPS 
$0.00
52 WEEK RANGE
$7.34 - $30.61
52 WEEK CHANGE
-$0.23
MARKET CAP 
108.034 M
YIELD 
N/A
SHARES OUTSTANDING 
5.164 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
N/A
BETA 
0.35
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$32,848
AVERAGE 30 VOLUME 
$64,541
Company detail
CEO:
Region: US
Website: www.opiant.com
Employees: 38
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Medicinal and Botanical Manufacturing
Sector: Manufacturing

Opiant Pharmaceuticals, Inc., the company that developed NARCAN® Nasal Spray, is building a leading franchise of new medicines to combat addictions and drug overdose.

Recent news